EUVIMEDEUVIMED entdecken
Crossref

Dying tumor cells-inspired vaccine for boosting humoral and cellular immunity against cancer

Xianya Qin, Ting Yang, Hongbo Xu, Runzan Zhang, Siyu Zhao, Li Kong, Conglian Yang, Zhiping Zhang

Journal of Controlled Release · 2023-07 · 359 · 359-372

DOI: 10.1016/j.jconrel.2023.05.044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-07. Verfasst von Xianya Qin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Melanoma. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Whole tumor cells can act as effective antigen depots and have been regarded as prospective candidate for cancer vaccines. However, the clinical outcomes of whole tumor cell vaccine were restricted by the poor immunogenicity and potential in vivo oncogenicity risks. Herein, a simple and effective cancer vaccine named frozen dying tumor cells (FDT) was constructed to initiate a cascade of immune attacks against cancer. By introducing immunogenic dying tumor cells and integrating cryogenic freezing technology, FDT was endowed with high immunogenicity, good in vivo safety, and long-time storage superiority. In syngeneic mice with malignant melanoma, FDT primed the polarization of follicular helper T cells and the differentiation of germinal center B cells in lymph nodes, and promoted the infiltration of cytotoxic CD8+ T cells in the tumor microenvironment, triggering the dual activation of humoral and cellular immunity. Of note, when combined with cytokines and immune checkpoint inhibitors, the FDT vaccine achieved 100% eradication of pre-existing tumors in mice, as demonstrated in the peritoneal metastasis model of colorectal carcinoma. Taken together, our work suggests an efficient cancer vaccine inspired by dying tumor cells and provides an alternative treatment candidate for cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesMelanomaMiceAnimalsCD8-Positive T-LymphocytesImmunity, HumoralImmunity, CellularTumor Microenvironment

Stichwörter der Autor:innen

Cancer vaccineCryogenic freezing techniqueDoxorubicinDying tumor cellsImmunogenic cell death

Substanzen

Cancer Vaccines

Autor:innen und Institutionen

  • Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China. Electronic address: conglianyang@hust.edu.cn.
  • Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China; Hubei Engineering Research Center for Novel Drug Delivery System, Wuhan 430030, China. Electronic address: zhipingzhang@mail…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Qin, X., Yang, T., Xu, H., Zhang, R., Zhao, S., Kong, L., Yang, C., & Zhang, Z. (2023). Dying tumor cells-inspired vaccine for boosting humoral and cellular immunity against cancer. Journal of Controlled Release, 359, 359-372. https://doi.org/10.1016/j.jconrel.2023.05.044

Vancouver

Qin X, Yang T, Xu H, Zhang R, Zhao S, Kong L, et al. Dying tumor cells-inspired vaccine for boosting humoral and cellular immunity against cancer. Journal of Controlled Release. 2023;359:359-372. doi:10.1016/j.jconrel.2023.05.044

BibTeX
@article{Qin2023,
  author = {Qin, Xianya and Yang, Ting and Xu, Hongbo and Zhang, Runzan and Zhao, Siyu and Kong, Li and Yang, Conglian and Zhang, Zhiping},
  title = {Dying tumor cells-inspired vaccine for boosting humoral and cellular immunity against cancer},
  journal = {Journal of Controlled Release},
  year = {2023},
  volume = {359},
  pages = {359--372},
  doi = {10.1016/j.jconrel.2023.05.044}
}
Kostenlos starten →